Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malaria is one of the world’s biggest killers. And our best weapon against it is at risk. We’re in a race against evolution - but what happens if we lose? This episode from The Economist series of 'The World if...' imagines what might happen if drug-resistant malaria spreads to Africa in the near future.

This video includes an interview of Professor Nick White, Professor of Tropical Medicine who works on malaria at our MORU research centre in Bangkok, Thailand.

Nick White

Malaria kills more than half a million people every year. Following a number of groundbreaking clinical trials, Professor Nick White and his Thailand team successfully demonstrated the effectiveness of artemisinin drug therapy for malaria in adults, children and infants. He also pioneered artemisinin combination therapy, the first-line treatment for malaria worldwide.

Outreach podcasts

Understanding great research doesn't have to be confusing. In this series of podcasts, our researchers explain what they get up to for a general audience.